EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy-Reference-Cited by-同舟云学术

EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy

Published:2019-04-15 Issue:2 Volume:51 Page:493-501
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Park Song Ee,Noh Jae Myoung,Kim You Jin,Lee Han Sang,Cho Jang Ho,Lim Sung Won,Ahn Yong Chan,Pyo Hongryull,Choi Yoon-La,Han Joungho,Sun Jong-Mu,Lee Se Hoon,Ahn Jin Seok,Park Keunchil,Ahn Myung-Ju

Funder

National Research Foundation of Korea

Ministry of Science, ICT and Future Planning

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://e-crt.org/upload/pdf/crt-2018-125.pdf

Reference25 articles.

1. A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer

2. Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer